AI Article Synopsis

  • Injuries to the upper extremity can lead to stiffness due to loss of elasticity in the joint capsule, and traditional rehab methods focus on capsule stretching.
  • This study tested the effectiveness of the Joint Active System static-progressive splint on patients with upper extremity stiffness who didn't improve with conventional therapies.
  • Results showed significant gains in range of motion for the elbow, wrist, and finger joints after using the splint, demonstrating its value in post-injury recovery.*

Article Abstract

Purpose: Injuries to the upper extremity often result in stiffness. The joint capsule may lose its elastic properties, limiting motion. Most modalities for increasing motion are based on capsule stretching, and usually involve physical or occupational therapy. We tested the hypothesis that the Joint Active System static-progressive splint is helpful in increasing range of motion in stiff joints after failure of other treatments.

Methods: Candidates for the Joint Active System splint were mostly patients with upper extremity trauma that required surgery, if they plateaued after therapy but still had stiffness. A retrospective review was performed of all patients from 2015 to 2019 that met our inclusion criteria. Etiologies of stiffness and patient demographics were documented. Range of motion was recorded before and after treatment and, when available, functional scores were calculated.

Results: Forty-four patients were treated with the Joint Active System splint; 5 were excluded, leaving 39 for analysis: 15 elbow, 14 wrist and 10 proximal interphalangeal joints. All patients had received therapy before using the Joint Active System and 11 had tried a dynamic splint in addition to therapy. All joints showed significant improvement in motion after treatment: from 66.5° to 95.7° in the elbow, 63.5° to 81.1° in the wrist and 33.2° to 51.8° in the proximal interphalangeal joint. When functional scores were available before and after treatment, there was significant improvement for both elbow and wrist. Even when the Joint Active System was started many months after injury, it was effective.

Conclusions: Despite reaching a plateau with therapy, the Joint Active System static-progressive splint is effective in improving range of motion in elbow, wrist and finger joints with stiffness following injury or surgery.

Type Of Study: Retrospective case series.

Level Of Evidence: Therapeutic, level IV.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hansur.2024.101710DOI Listing

Publication Analysis

Top Keywords

joint active
28
active system
28
system splint
12
upper extremity
12
range motion
12
elbow wrist
12
joint
10
system static-progressive
8
static-progressive splint
8
functional scores
8

Similar Publications

Using Multi-Omics Methods to Understand Gouty Arthritis.

Curr Rheumatol Rev

January 2025

Department of Rheumatology, Beijing Jishuitan Hospital, Guizhou Hospital, China.

Gouty arthritis is a common arthritic disease caused by the deposition of monosodium urate crystals in the joints and the tissues around it. The main pathogenesis of gout is the inflammation caused by the deposition of monosodium urate crystals. Omics studies help us evaluate global changes in gout during recent years, but most studies used only a single omics approach to illustrate the mechanisms of gout.

View Article and Find Full Text PDF

Antigen-presenting cells (APCs) process tumor vaccines and present tumor antigens as the first signals to T cells to activate anti-tumor immunity, which process requires the assistance of co-stimulatory second signals on APCs. The immune checkpoint programmed death ligand 1 (PD-L1) not only mediates the immune escape of tumor cells but also acts as a co-inhibitory second signal on APCs. The serious dysfunction of second signals due to the high expression of PD-L1 on APCs in the tumor body results in the inefficiency of tumor vaccines.

View Article and Find Full Text PDF

Constructing bifunctional electrocatalysts through the synergistic effect of diverse metal sites is crucial for achieving high-efficiency and steady overall water splitting. Herein, a "dual-HER/OER-sites-in-one" strategy is proposed to regulate dominant active sites, wherein Ni/Co(OH)-Ru heterogeneous catalysts formed on nickel foam (NF) demonstrate remarkable catalytic activity for oxygen evolution reaction (OER) as well as hydrogen evolution reaction (HER). Meanwhile, the potentials@10 mA cm of Ni/Co(OH)-Ru@NF for overall alkaline water and seawater splitting are only 1.

View Article and Find Full Text PDF

Ultrahigh-Selectivity Photocatalytic Upgrading of Bio-Aldehydes/Diols to Monoalcohols Via In Situ Circumventing Coupling Co-Products Over Janus Single-Atom Pd/TiO.

Small Methods

January 2025

State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide & Agricultural Bioengineering, Ministry of Education, State-Local Joint Laboratory for Comprehensive Utilization of Biomass, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, Guizhou, 550025, China.

Photocatalytic transfer hydrogenation of biomass-derived aldehydes to alcohols often results in unwanted coupling co-products. Herein, an ultraselective hydrogen transfer system enabled by in situ oxidative C─C bond cleavage over a Janus single-atom palladium on titanium dioxide (0.5Pd/TiO) photocatalyst is presented.

View Article and Find Full Text PDF

Discovery of Triketone-Indazolones as Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibiting-Based Herbicides.

J Agric Food Chem

January 2025

State Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, Central China Normal University, Wuhan 430079, PR China.

4-Hydroxyphenylpyruvate dioxygenase (HPPD) is a crucial herbicide target in current research, playing an important role in the comprehensive management of resistant weeds. However, the limited crop selectivity and less effectiveness against grass weeds of many existing HPPD inhibitors, limit their further application. To address these issues, a series of novel HPPD inhibitors with fused ring structures were designed and synthesized by introducing an electron-rich indazolone ring and combining it with the classical triketone pharmacophore structure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!